Skip to main content
. Author manuscript; available in PMC: 2019 Jun 28.
Published in final edited form as: JACC Clin Electrophysiol. 2018 Aug 29;4(10):1347–1358. doi: 10.1016/j.jacep.2018.06.012

FIGURE 1. Experimental Design and Determination of Minimal Effective Concentration of CaCl2.

FIGURE 1

(A) The experiment design for the 3 protocols. (B, C) The minimal effective concentration of CaCl2 to suppress ganglionated plexi (GP) function was 0.5 mmol/l. Level 1: stimulating voltage from 10 to 30 V; level 2: 40 to 60 V; level 3: 70 to 90 V; level 4: 100 to 120 V. *p < 0.05 versus baseline (BS) at different stimulation levels. ERP = effective refractory period; M = mol/l; MNP = magnetic nanoparticles; RAP = rapid atrial pacing.